Tolterodine
Top View
- Therapeutic Class Overview Urinary Antispasmodics
- Overactive Bladder
- A Straightforward Route to Enantiopure Pyrrolizidines And
- In Vivo Quantitative Autoradiographic Analysis of Brain Muscarinic Receptor Occupancy by Antimuscarinic Agents for Overactive Bladder Treatment
- (12) United States Patent (10) Patent No.: US 6,890,920 B2 Richards Et Al
- Comparison of Efficacy of Prophylactic Ketamine and Dexmedetomidine on Postoperative Bladder Catheter- Related Discomfort
- Management of Incontinence in Older Adults*
- Are Antimuscarinic Drugs Effective Against Urinary Frequency Mediated by Atropine-Resistant Contractions?
- Antihistamine Prior Authorization Review
- 3703-3712-Flavoxate in the Symptomatic Treatment of Overactive Bladder: a Meta-Analysis
- Patients with Dementia and Receiving Tricyclic Antidepressants Or Anticholinergic Agents
- Howcan Heat Illness Be Affected by Medications?
- The Pharmacology of Svt-40776, a New Muscarinic Antagonist for the Treatment of Urinary Incontinence
- Drug Class Review on Agents for Overactive Bladder
- Interactions with Entry & Integrase Inhibitors
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- DESCRIPTION DETROL LA Capsules Contain Tolterodine Tartrate. the Active Moiety, Tolterodine, Is a Muscarinic Receptor Antagonist
- Diphenhydramine (E.G., Benadryl)